- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/70 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 239/70
Total number of patents in this class: 511
10-year publication summary
|
39
|
24
|
26
|
30
|
27
|
19
|
14
|
29
|
8
|
12
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4001 |
46 |
| Array BioPharma Inc. | 497 |
23 |
| Boehringer Ingelheim International GmbH | 4646 |
20 |
| Merck Sharp & Dohme LLC | 3757 |
14 |
| Duquesne University of the Holy Spirit | 128 |
12 |
| F. Hoffmann-La Roche AG | 7947 |
11 |
| Reata Pharmaceuticals, Inc. | 117 |
11 |
| PTC Therapeutics, Inc. | 489 |
10 |
| Bristol-myers Squibb Company | 4855 |
8 |
| Janssen Pharmaceutica N.V. | 3362 |
8 |
| Merck Sharp & Dohme Corp. | 2191 |
7 |
| Tetra Discovery Partners, LLC | 11 |
7 |
| Samsung SDI Co., Ltd. | 8589 |
6 |
| The Regents of the University of Michigan | 4746 |
6 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 643 |
6 |
| Universal Display Corporation | 1934 |
6 |
| Hoffmann-La Roche Inc. | 3468 |
5 |
| Idemitsu Kosan Co., Ltd. | 4220 |
5 |
| ArQule, Inc. | 135 |
5 |
| Chimerix, Inc. | 89 |
5 |
| Other owners | 290 |